pLVX-EF1alpha-eGFP-2xStrep-IRES-Puro Citations (17)
Originally described in: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Huttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, Garcia-Sastre A, Shokat KM, Shoichet BK, Krogan NJ Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30. PubMed Journal
Articles Citing pLVX-EF1alpha-eGFP-2xStrep-IRES-Puro
| Articles |
|---|
| SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, Ramage HR, Cherry S, Jurado KA. PLoS One. 2021 Jun 24;16(6):e0253089. doi: 10.1371/journal.pone.0253089. eCollection 2021. PubMed |
| Effect of SARS-CoV-2 proteins on vascular permeability. Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, Miller V, Babich T, Shaked K, Ehrlich A, Ioannidis K, Nahmias Y, Sharan R, Ashery U, Maoz BM. Elife. 2021 Oct 25;10. pii: 69314. doi: 10.7554/eLife.69314. PubMed |
| Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity. Lopez-Munoz AD, Kosik I, Holly J, Yewdell JW. bioRxiv. 2021 Dec 13. doi: 10.1101/2021.12.10.472169. PubMed |
| Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes. Liu J, Zhang Y, Han L, Guo S, Wu S, Doud EH, Wang C, Chen H, Rubart-von der Lohe M, Wan J, Yang L. Stem Cell Reports. 2022 Mar 8;17(3):522-537. doi: 10.1016/j.stemcr.2022.01.014. Epub 2022 Feb 17. PubMed |
| SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome. Zaffagni M, Harris JM, Patop IL, Pamudurti NR, Nguyen S, Kadener S. Elife. 2022 Mar 16;11. pii: 71945. doi: 10.7554/eLife.71945. PubMed |
| Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Lopez-Munoz AD, Kosik I, Holly J, Yewdell JW. Sci Adv. 2022 Aug 5;8(31):eabp9770. doi: 10.1126/sciadv.abp9770. Epub 2022 Aug 3. PubMed |
| Cyclin D3 restricts SARS-CoV-2 envelope incorporation into virions and interferes with viral spread. Gupta RK, Mlcochova P. EMBO J. 2022 Nov 17;41(22):e111653. doi: 10.15252/embj.2022111653. Epub 2022 Oct 10. PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, Mao C, Luo Y, Judd J, Wierbowski S, Bertolotti M, Nerkar M, Jehi L, Drayman N, Nicolaescu V, Gula H, Tay S, Randall G, Wang P, Lis JT, Feschotte C, Erzurum SC, Cheng F, Yu H. Nat Biotechnol. 2023 Jan;41(1):128-139. doi: 10.1038/s41587-022-01474-0. Epub 2022 Oct 10. PubMed |
| SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D. Lee MJ, Leong MW, Rustagi A, Beck A, Zeng L, Holmes S, Qi LS, Blish CA. Cell Rep. 2022 Dec 27;41(13):111892. doi: 10.1016/j.celrep.2022.111892. Epub 2022 Dec 12. PubMed |
| Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism. Hajikhezri Z, Kaira Y, Schubert E, Darweesh M, Svensson C, Akusjarvi G, Punga T. J Virol. 2023 Feb 28;97(2):e0153922. doi: 10.1128/jvi.01539-22. Epub 2023 Feb 7. PubMed |
| Cell Surface Nucleocapsid Protein Expression: A Betacoronavirus Immunomodulatory Strategy. Lopez-Munoz AD, Santos JJS, Yewdell JW. bioRxiv [Preprint]. 2023 Feb 27:2023.02.24.529952. doi: 10.1101/2023.02.24.529952. PubMed |
| Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor. Lainscek D, Golob-Urbanc A, Mikolic V, Pantovic-Zalig J, Malensek S, Jerala R. Mol Ther Oncolytics. 2023 Apr 26;29:77-90. doi: 10.1016/j.omto.2023.04.005. eCollection 2023 Jun 15. PubMed |
| SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells. Kim IJ, Lee YH, Khalid MM, Chen IP, Zhang Y, Ott M, Verdin E. J Biol Chem. 2023 Aug;299(8):104955. doi: 10.1016/j.jbc.2023.104955. Epub 2023 Jun 23. PubMed |
| Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53. Lee JD, Menasche BL, Mavrikaki M, Uyemura MM, Hong SM, Kozlova N, Wei J, Alfajaro MM, Filler RB, Muller A, Saxena T, Posey RR, Cheung P, Muranen T, Heng YJ, Paulo JA, Wilen CB, Slack FJ. Cell Rep. 2023 Dec 26;42(12):113478. doi: 10.1016/j.celrep.2023.113478. Epub 2023 Nov 21. PubMed |
| Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors. Mikolic V, Pantovic-Zalig J, Malensek S, Sever M, Lainscek D, Jerala R. Mol Ther Oncol. 2024 May 14;32(2):200815. doi: 10.1016/j.omton.2024.200815. eCollection 2024 Jun 20. PubMed |
| SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR. Laprise F, Arduini A, Duguay M, Pan Q, Liang C. Viruses. 2024 Jun 22;16(7):1008. doi: 10.3390/v16071008. PubMed |
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids.
Broderick K, Moutaoufik MT, Saccon T, Malty R, Amin S, Phanse S, Joseph TP, Zilocchi M, Hosseinnia A, Istace Z, Hajikarimlou M, Abrar S, Fisher J, Brassard R, Perera R, Kumar A, Aoki H, Rahmatbakhsh M, Jessulat M, Kobasa D, Dehne F, Prasad B, Gagarinova A, Joanne Lemieux M, Cochrane A, Houry WA, Aly KA, Golshani A, Babu M.
Nat Commun. 2025 Jul 1;16(1):5784. doi: 10.1038/s41467-025-60949-1.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.